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Abstract
Background: The Foxl2 transcription factor is required for ovarian function during follicular development. The
mechanism of Foxl2 regulation of this process has not been elucidated. Our approach to begin to understand
Foxl2 function is through the identification of Foxl2 regulated genes in the ovary.
Methods: Transiently transfected KK1 mouse granulosa cells were used to identify genes that are potentially
regulated by Foxl2. KK1 cells were transfected in three groups (mock, activated, and repressed) and twenty-four
hours later RNA was isolated and submitted for Affymetrix microarray analysis. Genesifter software was used to carry
out analysis of microarray data. One identified target, the gonadotropin releasing hormone receptor (GnRHR) gene,
was chosen for further study and validation of Foxl2 responsiveness. Transient transfection analyses were carried
out to study the effect of Foxl2 over-expression on GnRHR gene promoter-luciferase fusion activity. Data generated
was analyzed with GraphPad Prism software.
Results: Microarray analysis identified 996 genes of known function that are potentially regulated by Foxl2 in
mouse KK1 granulosa cells. The steroidogenic acute regulatory protein (StAR) gene that has been identified as
Foxl2 responsive by others was identified in this study also, thereby supporting the effectiveness of our strategy.
The GnRHR gene was chosen for further study because it is known to be expressed in the ovary and the results of
previous work has indicated that Foxl2 may regulate GnRHR gene expression. Cellular levels of Foxl2 were
increased via transient co-transfection of KK1 cells using a Foxl2 expression vector and a GnRHR promoter-
luciferase fusion reporter vector. The results of these analyses indicate that over-expression of Foxl2 resulted in a
significant increase in GnRHR promoter activity. Therefore, these transfection data validate the microarray data
which suggest that Foxl2 regulates GnRHR and demonstrate that Foxl2 acts as an activator of the GnRHR gene.
Conclusions: Potential Foxl2 regulated ovarian genes have been identified through microarray analysis and
comparison of these data to other microarray studies. The Foxl2 responsiveness of the GnRHR gene has been
validated and provided evidence of Foxl2 transcriptional activation of the GnRHR gene promoter in the mouse
ovary derived KK1 granulosa cell line.
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The transcription factor Foxl2 is vital to ovarian func-
tion as evidenced by the identification of mutations in
the gene encoding FoxL2 that result in the condition
known as blepharophimosis/ptosis/epicanthus inversus
syndrome (BPES) and in some cases, premature ovarian
failure (POF) [1]. Type I BPES is characterized by eyelid
malformation and POF suggesting that the expression of
FoxL2 is critical in the developing eyelid as well as in
the maintenance of ovarian function. Foxl2 has also
been implicated in the process of sex determination in
mice [2] as well as in humans [3].
Foxl2 knockout studies in the mouse provide compel-
ling evidence of the critical role that Foxl2 plays in ovar-
ian function. In a study in which a portion of the Foxl2
coding region (amino acids N-61) was fused to the b-
galactosidase gene (LacZ), homozygous Foxl2-lacZ mice
exhibited ovarian failure resulting from the absence of
granulosa cell differentiation at an early stage of follicu-
lar development [4]. These investigators observed that
follicles were activated and underwent apoptosis, leading
to progressive follicular depletion and ovarian atresia. A
second study in which both copies of Foxl2 were com-
pletely knocked out determined that the development of
granulosa cells was blocked at the point of primordial
follicle formation [5].
In order to understand the mechanism through which
Foxl2 functions in follicular development, ovarian speci-
fic target genes must be identified. Microarray analysis
has been performed previously by other groups using
strategies that differ from this present study. The first
study involved over-expression of FoxL2 in the human
KGN granulosa cell line and Nimblegen gene chips [6].
A more recent study used Foxl2 knockout mice and
whole ovary preparations of RNA for their analyses.
Both Affymetrix and Agilent gene chips were used by
these investigators [7].
In this present study, mouse Foxl2 target genes were
identified using Affymetrix microarray analysis. The
effect of Foxl2 mediated gene regulation was examined
through the use of vectors expressing Foxl2 fusion pro-
teins designed to either activate or repress gene expres-
sion (fusions are described in Methods section below).
The KK1 mouse granulosa cell line is an excellent sys-
tem for these studies in that these cells exhibit granu-
losa cell characteristics such as gonadotropin
responsiveness and inhibin expression [8]. In addition,
KK1 cells are easy to maintain in culture and can be
transfected with high efficiency. The data generated
using the Affymetrix microarray analysis have been com-
pared to those found in the above mentioned studies
and many of the target genes identified are common to
those studies [6,7].
In addition, a candidate gene identified in the microar-
ray analysis was chosen for further study. The GnRHR
gene was chosen based on the results of our previous
study which implicated Foxl2 in the regulation of
GnRHR in the pituitary derived aT3-1 cell line [9]. This
present study provides the first evidence that Foxl2
affects the expression of GnRHR in the ovary. Foxl2 reg-
ulation of the GnRHR gene has been examined in KK1
granulosa cells through the use of transient co-transfec-
tion studies of a GnRHR promoter-luciferase fusion
construct and a wild type Foxl2 expression vector. The
results of these analyses suggest that Foxl2 is a positive
regulator of the murine GnRHR gene promoter.
Methods
Cell culture
The KK1 granulosa cell line was a gift from Dr. Ilpo
Huhtaniemi whose laboratory developed the cell line
and from Dr. Deborah Segaloff who sent us the cell line.
The cells are grown in DMEM/F12 (50/50) containing
10% heat inactivated FBS (Gemini Bioproducts; West
Sacramento, CA), 100 μg/ml penicillin-streptomycin,
and 0.25 μg/ml amphotericin B. All cell culture reagents
other than FBS were purchased from Mediatech; Mana-
ssas, VA.
Affymetrix microarray analysis
The KK1 granulosa cell line was chosen as a model sys-
tem for this study as a result of numerous published
studies as well as our own observations suggesting that
the site of action of Foxl2 during follicular development
is the granulosa cell. However, due to endogenous
expression of Foxl2 in KK1 cells, simple over-expression
resulting from transfection of a Foxl2 expression vector
may not affect levels of gene expression sufficiently to
be detected efficiently by microarray analysis. Therefore,
in order to increase the potential of Foxl2 to alter gene
expression levels of putative target genes, two fusions
were constructed consisting of Foxl2 fused to the activa-
tion domain of the Herpes simplex virus VP16 transcrip-
tion factor (Foxl2-VP16) and Foxl2 fused to the
repression domain of the murine MAD transcription
factor (Foxl2-MAD). Levels of gene expression were
compared between mock transfected cells and those
that were transfected with Foxl2-VP16 and Foxl2-MAD,
respectively.
Foxl2 fusion protein derivatives
The construction of Foxl2-VP16 was described pre-
viously and was shown to function as a specific activator
of transcription [9]. Foxl2-MAD consists of the 40
amino acid N-terminal mSin3 interaction domain (SID)
of the Mad transcription factor fused to Foxl2 in the
expression vector pcDNA 3.1 (Invitrogen Corporation;
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mediated through interactions of the Mad N-terminus
with the mammalian Sin3 co-repressor protein [10,11].
The effectiveness of the Sin3 binding domain of Mad in
silencing gene expression when fused to DNA binding
proteins has been demonstrated in two studies. One
g r o u pf u s e dt h eM a dS I Dt ot h ec-Jun DNA binding
domain and demonstrated specific inhibition of tran-
scription mediated by binding to AP-1 binding site ele-
ments [12]. Another group of investigators fused Mad
SID to the tetracycline receptor and demonstrated tetra-
cycline mediated gene repression via binding to the tet-
racycline operator sequence [11]. The ability of Foxl2-
Mad and Foxl2-VP16 fusion constructs was tested utiliz-
ing the Foxl2-VP16 responsivel u c i f e r a s er e p o r t e r3 X -
GRAS-Luc [9]. In transient transfections of KK1 cells,
Foxl2-VP16 resulted in a greater than 50-fold increase
in luciferase expression. The co-transfection of Foxl2-
Mad attenuated the ability of Foxl2-VP16 to activate
luciferase expression by 95% (data not shown). There-
fore, these fusion vectors are appropriate for activation
and repression studies of Foxl2 specific genes.
Microarray transfection
KK1 cells were grown in 150 mm tissue culture plates
t o5 0 %c o n f l u e n c e .T h r e ep l a t e sw e r em o c kt r a n s f e c t e d
with 30 μl of Fugene 6 transfection reagent (Roche
Applied Science; Indianapolis, IN) and 10 μg of empty
vector (pcDNA 3.1). Three plates were transfected with
10 μg of Foxl2-VP16 expression vector in 30 μlF u g e n e
reagent and 3 plates were transfected with 10 μgo f
Foxl2-MAD expression vector in 30 μl Fugene reagent.
After 24 hours incubation at 37°C the cells were har-
vested and polyA
+ RNA was isolated using RNeasy (Qia-
gen Inc.; Valencia, CA) according to manufacturer’s
procedures. Ten μg of RNA isolated from each plate
were diluted to a concentration of 1 μg/μl and a total of
9 samples were submitted to the Colorado State Univer-
sity Affymetrix core facility for analysis.
Microarray and data analysis
Nine Affymetrix mouse genome 430 2.0 chips were used
(one for each plate of KK1 cells). Our microarray data
can be downloaded from the web site, http://www.ncbi.
nlm.nih.gov/geo, via the accession number GSE18891.
Data obtained from the chips was analyzed using the
Genesifter Program (VizX Labs LLC; Seattle, WA).
Two independent analyses were performed. In the
first, our data was analyzed using pairwise analysis,
mean normalization, and T-test statistical analysis (P <
0.05). In the second, we compared our data to that of
Garcia-Ortiz et al. [7]. Eighteen Affymetrix CEL files
representing the developmental stage embryonic days 13
and 16, and birth were downloaded from http://www.
ncbi.nlm.nih.gov/geo, via the accession number
GSE12989 [7]. These files were uploaded along with our
9 Affymetrix CEL files together into Genesifter for analy-
sis using the MAS5 advanced upload method. A project
analysis in was set up in Genesifter with the following
parameters: the cutoff threshold was set at 1.8 fold with
T-test statistical analysis (mouse) or anova (KK1), and P
< 0.05.
Transient co-transfection and luciferase assays
Expression vectors
The original GnRHR promoter luciferase fusion reporter
vector (pMGR-600 Luc) was described previously [13].
In this study, the plasmid -600 Luc was created by sub-
cloning the 600 base pair fragment of the mouse
GnRHR promoter into the expression vector pGL3 basic
(Promega Corporation; Madison, WI). The Foxl2
expression vector (pFoxl2) consists of the mouse Foxl2
open reading frame inserted in pCDNA 3.1 (Invitrogen
Corporation; Carlsbad, CA). The renilla luciferase con-
trol vector phRL-CMV is part of the dual luciferase
assay system (Promega Corporation; Madison, WI).
Transfection
KK1 cells were plated at a density of 2.5 × 10
5 cells per
well of 24 well tissue culture plates the day the transfec-
tions were carried out. Transfections included 0.3 μg
-600 Luc reporter plasmid, 3 ng of phRLCMV renilla
luciferase vector to normalize for transfection efficiency,
and either 0.3 μg pcDNA 3.1 (as a control) or 0.3 μg
pFoxl2. DNA was mixed with DMEM/F12 medium con-
taining Fugene 6 reagent (Roche Applied Science; India-
napolis, IN) at a ratio of 4:1 Fugene to total DNA and
added to cells.
Luciferase assays
Transfected cells were incubated for 24 hours at 37°C
and washed 3 times with phosphate buffered saline.
Cells were lysed and the Dual-luciferase assay was per-
formed according to manufacturer’s instructions (Pro-
mega Corporation; Madison, WI) using a 20/20
n
luminometer (Turner Biosystems; Sunnyvale, CA). Each
transfection was carried out in triplicate and experi-
ments were carried out a total of 4 times. Data was ana-
lyzed with the paired T-test using GraphPad Prism
software (GraphPad Software, Inc.; La Jolla, CA).
Results
Affymetrix microarray analysis
In order to increase the effectiveness of this analysis,
Foxl2 derivatives consisting of the entire open reading
frame of Foxl2 fused to either the strong transcriptional
activation domain of Herpes simplex virus VP16 [9] or
the Mad protein-SID domain, a repressor of transcrip-
tion [10,14] were used. These Foxl2 fusion proteins can
be used as tools for gene discovery as the DNA binding
domain of Foxl2 will guide either the activation or
repression domain to the promoter regions of genes
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binding. Theoretically, Foxl2-VP16 should stimulate
genes that are normally regulated by Foxl2, particularly
those that are normally repressed in KK1 cells. Conver-
sely, Foxl2-MAD should function to repress genes nor-
mally regulated by Foxl2, especially those that are
normally active in KK1 cells. In this study, levels of gene
expression in murine KK1 granulosa cells transfected
with the fusion protein expression vectors were com-
pared to mock transfected cells. A pairwise analysis was
performed with the following groupings: mock vs. VP16
transfected cells (group NA); mock vs. Mad transfected
cells (group NR); and Mad vs. VP16 transfected cells
(group RA). The cumulative listings of genes for these
groups are found in Additional Files 1, 2, and 3 respec-
tively. The results of the pairwise analysis are summar-
ized in the comprehensive listing of 636 potential
targets of the Foxl2 transcription factor (Additional File
4). Only genes of known function are listed and all
exhibited at least a 1.75 fold change in expression levels.
In order to validate these findings, we carried out a
comparison of our data to data derived from two other
microarray studies [6,7]. One group used the human
KGN granulosa cell line and over-expression of FoxL2
to identify potential targets and qPCR to confirm
numerous FoxL2 regulated genes [6]. A second group
used mouse Foxl2 knockouts and whole ovarian pre-
p a r a t i o n sf o rm i c r o a r r a ys t u d i e sa sw e l la sa n a l y s i so f
other investigator’s microarray data [7].
Garcia-Ortiz et al. [7] used Affymetrix gene chips
identical to those used in our study to compare develop-
mental stage specific gene expression levels in ovary
preparations from wild type and Foxl2 knockout mice at
embryonic day 13 (E13), embryonic day 16 (E16), and
birth (P0). This allowed us to compare our raw data
directly to theirs and determine the similarity between
differentially expressed genes in our KK1 study and
their stage specific study. In this analysis, we compared
differentially expressed genes from mock, VP16, and
Mad transfected KK1 cell groups combined (Additional
file 5) to mouse samples [7] that compared wild type to
Foxl2 knockout for stages E13 (Additional file 6); E16
(Additional file 7), and P0 (Additional file 8).
The “Intersector” subroutine in Genesifter allowed us
to find commonalities between the groups of genes in
A d d i t i o n a lf i l e s5 ,6 ,7 ,8 .T h ec o m p a r i s o n sa r et h ef o l -
l o w i n g :K K 1v s .E 1 6 ,K K 1v s .E 1 3 ,a n dK K 1v s .P 0( F i g -
ure 1 and Additional file 9). This analysis resulted in the
discovery of 360 new genes of known function that were
shared between the KK1 and mouse ovary studies
increasing the total number of potential Foxl2 target
genes to 996 (Additional file 4).
We then turned our attention to the human KGN cell
line study of Batista et al. [6]. In comparing their
confirmed human gene list to our mouse gene list, 3
common genes were identified. These were Mrgpre,
Maff,a n dRspo3 (Additional file 10). Comparison of
their comprehensive listing with our study’s list of genes
resulted in finding a total of 42 genes common to both
(Additional file 10).
In order to begin to understand the significance of the
genes common to the three microarray studies in the
ovary, we then searched the Ovarian Kaleidoscope Data-
base (OKdb) to determine if other investigators had
published evidence of ovarian expression of these genes.
A total of 71 of the genes were found to be expressed in
the ovary and have been categorized according to func-
tion: Gene Regulation (Table 1), Signaling (Table 2), and
Metabolism, Cell Adhesion, Cytoskeletal, and Structural
(Table 3).
T h r e eo ft h eg e n e st h a tw eh a v ei n c l u d e di nT a b l e2
were not found in the OKdb: Mrgpre, Ctla4 and Eda.
These are potentially important due to the fact that they
are common to all three studies. The StAR gene was not
found in either of the other group’sd a t as e t sb u t
included in Table 3 because it has been shown to be a
human Foxl2 target gene [15]. Our finding that the
mouse StAR gene is a Foxl2 target validates the
approach chosen for this study. The GnRHR gene was
not found in either of the other group’sd a t as e t sa n di s
noted in Table 2 because further evidence of Foxl2 reg-
ulation of this gene is provided in the section that
follows.
Transient co-transfection and luciferase assays
Transient co-transfection studies to determine the Foxl2
regulation of the GnRHr promoter were carried out
using KK1 cells transfected with various combinations
of luciferase reporter vectors and pcDNA 3.1 expression
vectors. The effect of Foxl2 over-expression on the
activity of the GnRHR promoter was determined by
comparing the luciferase activity of the promoter in the
presence of pFoxl2 (over-expression) to the activity of
the promoter in the absence of Foxl2 over-expression
(pcDNA 3.1). Foxl2 over-expression activated the
GnRHR promoter 5.8 fold (Figure 2).
Discussion
This study has resulted in an increased awareness of
Foxl2 function in the ovary. First, through the use of
microarray analysis we have added to the growing list of
genes that appear to be regulated by Foxl2 and thus
may play a role in follicular development in the ovary.
Second, we have demonstrated the GnRHR gene promo-
ter is regulated in a positive manner by the transcription
factor Foxl2 in the KK1 granulosa cell line.
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In an effort to increase the level of differential gene
expression that could be induced by Foxl2 and thereby
efficiently detected by microarray analysis, we have used
Foxl2 derivatives in this study. This approach appears to
have succeeded in that the mouse StAR gene was
detected and had been previously demonstrated to be
Foxl2 responsive in a human system [15]. Based on our
experimental design, we would have predicted that in
comparing mock to Foxl2-VP16 transfected cells (NA)
all values would be positive due to VP16 transactivation.
However, in looking through the genes beginning with
the letter “A” in our comprehensive alphabetical listing
(Additional file 4), 16 out of 22 in the NA category were
negative. The simplest explanations for repression of
gene expression by VP16 are provided by the authors of
a study that also used a VP16 fusion for microarray ana-
lysis and also noted unexpected negative regulation [16].
These investigators speculated that VP16 caused the
Figure 1 Comparison of differential gene expression in KK1 cells to mouse ovary developmental stages. Genesifter software was used to
determine differentially expressed genes in KK1 cells and mouse in vivo samples [7]. The KK1 analysis for differentially expressed genes
generated a cumulative listing of 2520 differentially expressed genes among the mock, VP16, and mad transfected cell groups combined
(Additional file 5). The mouse samples compared wild type to knockout for each stage as follows: E13, 3289 genes (Additional file 6); E16, 2995
genes (Additional file 7); and P0, 4330 genes (Additional file 8). Comparisons between groups of genes were performed with Genesifter
Intersector. The comparisons are represented by circles and are as follows: KK1 vs. E16; KK1 vs. E13; and KK1 vs. P0. The number of genes in each
grouping corresponding to color codes is indicated on the right. A listing of all genes may be found in Additional file 9.
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Gene
Symbol
Name Entrez
Gene ID
Group
Bcl11a** B cell CLL/lymphoma 11a (zinc finger protein) 14025 MA -4.5
Bub3 Budding uninhibited by benzimidazoles 3 homolog 12237 E16
Cdc25a Cell division cycle 25 homolog A (S. pombe) 12530 P0
Dazl deleted in azoospermia-like 13164 MA -3.1
Etv1 Ets variant gene 1 14009 RA+6.5, E16
Gabpa GA repeat binding protein, alpha 14390 P0
Greb1 Growth regulation by estrogen in breast cancer 1 268527 E13, E16
Hoxb5** Homeo box B5 15413 RA-5.1, E16
Id4 Inhibitor of DNA binding 4 15904 MA -5.6
Mcm7 Minichromosome maintenance deficient 7 17220 E16, P0
Nr4a2 Nuclear receptor subfamily 4, group A, member 2 18227 E16
Plagl1 pleiomorphic adenoma gene-like 1 22634 MA +5.3
Serpine2 serine (or cysteine) peptidase inhibitor, clade E, member 2 20720 MR +2.4
Snw1 SNW domain containing 1 66354 E16, P0
Sox21* SRY-box containing gene 21 223227 MR +2.5
Zfp106 zinc finger protein 106 20402 MR +5.1
All genes listed that do not have an asterisk after the gene symbol are common to our study and the in vivo in mouse ovary study only [7]. Genes denoted by a
single asterisk* are common to our study and the human KGN cell line only [6]. Those indicated by ** are common to all three studies. The (-) symbol indicates
fold decreased expression. The (+) symbol indicates fold increased expression. MA compares mock (M) transfected cells to activated (A) cells (Foxl2-VP16
transfected). MR compares mock (M) transfected to repressed (R) cells (Foxl2-Mad transfected). RA compares repressed to activated cells. E16 and E13 are mouse
embryonic stages day 16 and 13, respectively. P0 is mouse birth stage.
Table 2 Signaling
Gene Symbol Name Entrez
Gene ID
Group
Akt1 Thymoma viral proto-oncogene 1 11651 E16
Akt2 Thymoma viral proto-oncogene 2 11652 P0
Ccr2 chemokine (C-C motif) receptor 2 12772 RA +4
Ctla4** cytotoxic T-lymphocyte-associated protein 4 12477 RA -5.2
Dlg5 Discs, large homolog 5 71228 MA -3.7, RA -3.6
Eda** ectodysplasin-A 13607 RA -3.9
Fgf8 fibroblast growth factor 8 14179 MR -4.8
Gnrhr*** Gonadotropin releasing hormone receptor 14715 MA -2.5, MR -3.3
Gucy1b3 Guanylate cyclase 1, soluble, beta 3 54195 MR -2.7
Irak1 Interleukin-1 receptor associated kinase 1 16179 E16
Ltk Leukocyte tyrosine kinase 17005 MA -2.9
Mrgpre** MAS-related GPR, member E 244238 NA-1.91
Npy1r* Neuropeptide Y receptor Y1 18166 RA-1.79
Pard3 Par-3(partitioning defective 3)homolog(C. elegans) 263803 E13
Ppp1r1b Protein phosphatase1, regulatory(inhibitor)subunit 1 19049 P0
Prlr Prolactin receptor 19116 MA -7.3, MR -7.3
Ptpn6** Protein tyrosine phosphatase, nonreceptor type 6 15170 MR-2.5, RA+2.1
Reln* Reelin 19699 MR +7.7
Slit2 Slit homolog 2 (drosophila) 20563 MA -6, MR -11.6
Stc1 Stanniocalcin 1 20855 P0
Stk3 Serine/threonine kinase 3(STE20 homolog, yeast) 56274 E16
Thbd* Thrombomodulin 21824 NA-2.3, NR-2.5
Tmsb10 Thymosin, beta 10 19240 RA +3.4
Wnt9a Wingless related MMTV integration site 9a 216795 P0
All genes listed that do not have an asterisk after the gene symbol are common to our study and the in vivo in mouse ovary study only [7]. Genes denoted by a
single asterisk* are common to our study and the human KGN cell line only [6]. Those indicated by ** are common to all three studies. The (-) symbol indicates
fold decreased expression. The (+) symbol indicates fold increased expression. MA compares mock (M) transfected cells to activated (A) cells (Foxl2-VP16
transfected). MR compares mock (M) transfected to repressed (R) cells (Foxl2-Mad transfected). RA compares repressed to activated cells. E16 and E13 are mouse
embryonic stages day 16 and 13, respectively. P0 is mouse birth stage.
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activity [16].
The repressor induction mechanism for VP16 repres-
sion is a distinct possibility in light of recent studies
that have explored the mechanisms involved in the con-
trol of Foxl2 transactivation activity. These investigators
found that deacetylation of the Foxl2 protein by the
SIRT1 deacetylase causes a decrease in Foxl2 transacti-
vation [17]. Sirt1 was also identified as a Foxl2 regulated
gene that is activated by Foxl2 [18]. In addition, these
investigators demonstrated that the Foxl2 promoter is
repressed by Sirt1 expression as part of a feedback
mechanism of regulation in response to stress [18].
Therefore, Sirt1 induction could alter the activity of
Foxl2-VP16, as well as repress other genes, resulting in
down regulation of genes in Foxl2-VP16 transfected
cells. A specific example is a study demonstrating that
Sirt1 deacetylation of AP1 modulates its function and
causes repression of the Cox2 gene [19].
The comparison of mock to Foxl2-Mad transfected
cells (NR) of genes beginning with the letter “A” reveals
10 out of 12 are negatively regulated as expected (Addi-
tional file 4). The finding that only 2 out of the 12 were
activated by Mad domain repression suggests that
Foxl2-Mad functions more reliably as a repressor in
comparison to Foxl2-VP16 as an activator in our study.
Perhaps this is due to the Mad repression domain inter-
acting specifically with the Sin3 complex deacetylase
leading to chromatin remodeling [10]. On the other
hand, the VP16 activation domain mechanism of trans-
activation is the result of interactions with a variety of
factors including histone acetylases, basal transcription
factors, and the coactivators CBP and Mediator to name
a few [20,21]. Therefore, over-expression of VP16 fusion
proteins may lead to repression due to competition for
the factors needed for endogenous gene expression [22].
With this in mind, the use of an alternative activation
domain with greater specificity in its interactions would
have resulted in fewer false repression events. However,
we should reiterate that this microarray study was
intended to provide a listing of potential Foxl2 target
genes and does not have the potential to discern Foxl2
regulatory mechanisms.
This study has compared microarray data from two in
vitro studies that utilized the human KGN [6] and
mouse KK1 (this study) cell lines respectively, and an in
vivo study that used mouse Foxl2 knockouts [7]. The
KK1 cell line was derived from a transgenic female
mouse in which SV40 T antigen expression was driven
by a 6 Kb inhibin alpha promoter fragment [8]. The
mouse developed a large ovarian tumor that was col-
lected after 5 months. The tumor cells had the morpho-
logical characteristics of granulosa cells. Subcultures
were tested for their cAMP and steroidogenic response
to chorionic gonadotropin and the culture with the
strongest response (KK1) was characterized further. The
KK1 cells were shown to be immortalized luteinizing
granulosa cells that expressed LH and FSH receptors,
steroidogenic enzymes, and inhibin alpha [8]. The KGN
cell line was derived from a 73 year old woman in
which granulosa cell carcinoma had recurred [23]. The
KGN cells had steroidogenic activities similar to those
of normal human granulosa cells and expressed func-
tional FSH receptor [23]. Therefore, in comparisons of
Table 3 Metabolism/Cell Adhesion/Cytoskeletal/Structural
Gene Symbol Name Entrez Gene ID Group
Acta2 Actin, alpha 2, smooth muscle, aorta 11475 E16
Bpgm 2,3-bisphophoglycerate mutase 12183 E16, P0
Casq1 Calsequestrin 1 12372 RA +4.4
Dlg5 Discs, large homolog 5 71228 NA-3.7, RA-3.6, E13
Erp29 Endoplasmic reticulum protein 29 67397 E16, P0
Hspg2 Heparin sulfate proteoglycan 2 15530 E16, P0
Itih5 Inter-alpha (globulin) inhibitor H5 209378 E16
Klk13* Kallikrein related-peptidase 13 626834 RA +3.3
Odc1 Ornithine decarboxylase, structural 1 18263 E16
Slc12a2 Solute carrier family 12, member 2 20496 E16, P0
StAR*** Steroidogenic acute regulatory protein 20845 MA+2.7, MR+3.9
Thbs2 Thrombospondin 2 21826 E13, E16
Usp9x Ubiquitin specific peptidase 9, X chromosome 22284 E13, P0
Vldlr Very low density lipoprotein receptor 22359 MR +2.1
All genes listed that do not have an asterisk after the gene symbol are common to our study and the in vivo in mouse ovary study only [7]. Genes denoted by a
single asterisk* are common to our study and the human KGN cell line only [6]. Those indicated by ** are common to all three studies. The (-) symbol indicates
fold decreased expression. The (+) symbol indicates fold increased expression. MA compares mock (M) transfected cells to activated (A) cells (Foxl2-VP16
transfected). MR compares mock (M) transfected to repressed (R) cells (Foxl2-Mad transfected). RA compares repressed to activated cells. E16 and E13 are mouse
embryonic stages day 16 and 13, respectively. P0 is mouse birth stage.
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derived from the KGN and KK1 cell lines is representa-
tive of well differentiated granulosa cells while the
mouse microarray data (E13, E16, and P0) represents
less differentiated granulosa cells from embryonic stages
and birth [7].
As seen in Figure 1, we do find evidence that this
assumption is correct when we compare the number of
genes shared between KK1 cells and the in vivo mouse
data of Garcia-Ortiz et al. [7]. The number of shared
genes increases from the embryonic stages (211&225
genes respectively) to 325 genes at birth (P0), indicating
that KK1 cells have transcriptional profile more like that
of a mature granulosa cell in vivo. Further similarities as
well as differences in shared genes among the three
comparison groups represented by the different colors
in Figure 1 can be found in individual sheets in Addi-
tional file 9. Of the five genes that are shared by all
groups (Figure 1-white), three have known functions:
Pa2g4, Rab28,a n dThbs2. Pa2g4 stands for prolifera-
tion-associated 2G4, a transcription factor involved in
cell growth and signalling [24]. Rab28 is a Ras oncogene
family member involved in the regulation of membrane
trafficking [25]. Thbs2 is also found in Table 3, and
encodes thrombospondin 2, an antiangiogenic protein
involved in follicle development [26]. The two genes of
unknown function are RIKEN cDNA 5033428C03 which
encodes the hypothetical protein LOC74728 (entrez
gene ID 74728) and Ta0871 that encodes a hypothetical
protein from Thermoplasma acidophilum (entrez gene
ID 1456410).
Comparison of our microarray data and comprehen-
sive listing of potential Foxl2 target genes (Additional
file 4) to those generated by two other groups of investi-
gators [6,7] has allowed us to generate a subset of Foxl2
targets that have greater potential of being Foxl2 regu-
lated (Additional file 10). Of particular interest are the
genes that are common to all three studies: Bcl11a,
Hoxb5, Mrgpre,a n dPtpn6 (Tables 1 and 2). The func-
tions of these genes are described below.
Mrgpre,a l o n gw i t hMaff and Rspo3,a l s oa p p e a ro n
the qPCR confirmed gene listing of Batista et al. [6].
The Mrgpre gene product is a Mas1 related G protein
coupled receptor that may be involved in the sensation
or modulation of pain in a subset of sensory neurons
[27]. Maff stands for v-maf musculoaponeurotic fibro-
sarcoma oncogene homolog f (avian). The protein
encoded by the gene is a basic-leucine zipper (bZIP)
transcription factor that is up-regulated by pro-inflam-
matory cytokines in myometrial cells [28]. Rspo3
encodes R-spondin 3, a secreted protein that mediates
Wnt signaling and is involved in angiogenesis during
mouse development [29].
Finally, the OKdb was utilized to identify genes from
this study that were demonstrated to be expressed in
the ovary in previous studies. These genes have been
divided into three tables based on known functions: 1.
gene regulation; 2. signaling; and 3. metabolism, cell
adhesion, cytoskeletal, and structural. Our focus now
turns to a discussion regarding the functions of genes
listed in Tables 1, 2, 3 that are known to be expressed
in granulosa cells (OKdb).
I nt h ea r e ao fg e n er e g u l a t i o n( T a b l e1 ) ,Bcl11a and
Serpine2 are expressed in granulosa cells although their
function in the ovary is unknown. The zinc finger tran-
scription factor Bcl11a was shown to be up-regulated in
human granulosa cells treated with FSH [30]. In human
erythroid cells where much more is known about the
factor, the Bcl11A protein functions as a repressor and
is involved in silencing fetal hemoglobin expression in
adults [31]. Serpine2 is a serine protease inhibitor that is
differentially expressed in large and small follicles in
sheep [32]. Serpine2 protein levels are elevated in domi-
nant bovine follicles [33], whereas the levels of Serpine2
are lower in ovaries of Foxl2 knockout mice suggesting
that the gene is induced by Foxl2 [7]. Gabpa and Nr4a2
are two genes in this category that have been
Figure 2 Foxl2 over-expression causes activation of the GnRHR
promoter. The GnRHR promoter-firefly luciferase vector (-600 Luc)
was co-transfected with either pFoxl2 or pcDNA 3.1. All transfections
included the control vector phRLCMV that expresses renilla
luciferase to correct for differences in transfection efficiency
between samples. Firefly luciferase values were divided by renilla
luciferase values to normalize for transfection efficiency. As an
additional control, the promoter-less luciferase vector (pGL3 basic)
was transfected with either the empty vector pCDNA3 or Foxl2
expression vector (pFoxl2) in order to show that Foxl2 did not affect
the luciferase control vector (Data not shown). Data from four
independent transfection experiments was combined to generate
the graph in Figure 1. Each of the four experiments was performed
in triplicate for a total of 12 data points represented in each
column. Each of the experiments used different KK1 cell cultures
and DNA preparations. Statistical analysis using GraphPad Prism
software (paired T-test; p = 0.0067**) allowed us to determine that
Foxl2 over-expression caused a 5.8 fold increase in promoter
activity.
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losa cell function. Gabpa is an ETS family transcription
factor that regulates the Rhox5 homeobox gene in rat
granulosa cells [34]. In the regulation of the nicotinic
acetylcholine receptor gene, Gabpa recruits the histone
acetyl transferase p300 when the promoter is activated,
and recruits the histone deacetylase HDAC1 when the
promoter is not activated [35]. Nr4a2 was found to be
r a p i d l yi n d u c e db yc A M Pi nt h eK G Ng r a n u l o s ac e l l
line [36]. LH was shown to induce Nr4a2 expression in
mouse granulosa cells [37].
Six genes involved in signaling (Table 2) are expressed
in granulosa cells. Akt1 is a component of the phosphoi-
nositide 3’-OH kinase (PI3K) pathway and is phosphory-
lated in response to Igf1 stimulation of bovine granulosa
cells [38]. Akt1 has also found in human granulosa cells
during follicle development [39]. The human GnRH
receptor has been shown to be expressed predominantly
in granulosa cells of pre-ovulatory follicles [40]. The
role of GnRH in the ovary is diverse as it regulates ster-
oidogenesis, cell proliferation, and apoptosis [41].
Gucy1b3 encodes a guanylate cyclase that is activated by
nitric oxide (NO) and is expressed at high levels in
granulosa cells of primordial and primary follicles of the
rat ovary [42]. NO has been shown to inhibit estrogen
production in rat granulosa cells [43] and steroidogen-
esis in porcine granulosa cells [44]. Ppp1r1b is a protein
phosphatase involved in signal transduction pathways in
human granulosa cells in response to dopamine and
human chorionic gonadotropin stimulation [45]. Prlr
encodes the prolactin receptor which is localized to
granulosa cells as well as other cell types in the rat
ovary [46]. Prolactin receptor expression in rat granu-
losa cells is increased by treatment of cultured cells with
FSH, LH and hCG [47]. Ptpn6 encodes a protein tyro-
sine phosphatase that is involved in modulating the sig-
naling cascade activated by PRL in granulosa cells [48].
The Ctla4, Eda,a n dMrgpre genes are in the signaling
category but are not found in the OKDB. However, they
are worthy of mention due to appearing in this study as
well as both the human KGN study [6] and the mouse
knockout study [7]. Ctla4 encodes cytotoxic T-lympho-
cyte associated protein 4, a receptor/signal transducer
that suppresses immune system function and is regu-
lated by the forkhead transcription factor FoxP3 [49-51].
Transcriptional regulation of Ctla4 by Foxl2 in granu-
losa cells may be the result of similarities in the Fork-
head binding sequence elements in the Ctla4 promoter
that allow both factors to regulate the gene, with cell
type determining the presence of either FoxP3 or Foxl2
in T cells or granulosa cells respectively. The Eda gene
encodes the protein ectodysplasin A, a tumor necrosis
factor family member with several isoforms, one of
which is a transmembrane protein [52]. Mutations in
the soluble form of the EDA protein and the EDA
receptor are the cause of anhidrotic ectodermal dyspla-
sia, a syndrome that results from impaired development
of skin appendages during embryogenesis [53].
Genes in Table 3 that have been shown to be
expressed in granulosa cells include Hspg2,a na n t i c o a -
gulant heparin sulfate proteoglycan involved in follicle
development and ovulation in rats[54]. Hspg2 had also
been found in human follicular fluid [55]. Odc1 encodes
ornithine decarboxylase 1 (ODC1), the rate-limiting
enzyme of the polyamine biosynthesis pathway which
catalyzes ornithine to putrescine. ODC1 expression is
stimulated by LH in granulosa cells and may mediate
the effects of LH during the process of follicular devel-
opment [56]. Thbs2 encodes thrombospondin 2, an anti-
angiogenic protein involved in follicle development [26].
Two genes involved in metabolism, StAR and Vldlr,
are expressed in granulosa cells and the gene products
of both are involved in steroidogenesis. StAR encodes
the steroidogenic acute regulatory protein, which trans-
fers cholesterol from the outer to the inner mitochon-
drial membrane, the rate limiting step in steroidogenesis
[57]. Vldlr encodes the very low density lipoprotein
receptor, which obtains lipoproteins from plasma, a
source of cholesterol for steroidogenesis [58].
Transient co-transfection and luciferase assays
Foxl2 over-expression resulted in a 6 fold activation of
the GnRHR gene promoter in transient co-transfections
of KK1 cells. This was the first demonstration of Foxl2
regulation of the GnRHR gene in ovarian derived cells.
Our previous study had demonstrated that Foxl2 could
potentially regulate the GnRHR promoter in pituitary
derived aT3-1 cell line based on activation by the
Foxl2-VP16 fusion protein [9]. Foxl2-VP16 action was
directed by binding to the GRAS element with the
potential for complex formation with Smad and AP1
transcription factors [9]. Whether a similar mechanism
or alternative binding site(s) are involved in granulosa
cells has not been determined.
Only a few Foxl2 target genes in the ovary have been
confirmed through promoter cloning and reporter gene
fusion analysis. The goat CYP19 gene, which encodes
the enzyme aromatase, was activated by Foxl2 [59]. The
human StAR gene, encoding the steroidogenic acute reg-
ulatory protein, is repressed by FoxL2 [15]. We have evi-
dence that the mouse StAR gene is also repressed by
Foxl2 (in preparation).
Conclusions
We have identified potential Foxl2 regulated ovarian
genes through microarray analysis and comparison of
o u rd a t at ot h a tf r o mo t h e rm i c r o a r r a ys t u d i e s .F o x l 2
derivatives with either activation or repression domains
Escudero et al. Journal of Ovarian Research 2010, 3:4
http://www.ovarianresearch.com/content/3/1/4
Page 9 of 12were used in this gene discovery process. Foxl2 regula-
tion of steroidogenesis appears to be of importance in
the ovary, as many of the genes we identified appear to
be involved either directly or indirectly in the process.
These include GnRHR, Gucy1b3, Prlr, Ptpn6, StAR and
Vldlr.
The GnRHR gene identified through microarray analy-
sis has been validated as Foxl2 responsive through pro-
moter cloning and reporter gene analysis. Transient co-
transfections of a GnRHR-luciferase reporter vector and
a wild-type Foxl2 expression vector provided evidence
of Foxl2 transcriptional activation of the GnRHR gene
promoter in the mouse ovary derived KK1 granulosa
cell line.
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Additional file 1: Pairwise analysis of differentially expressed genes
in KK1 cells. Group NA: mock vs. VP16.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
S1.XLS]
Additional file 2: Pairwise analysis of differentially expressed genes
in KK1 cells. Group NR: mock vs. Mad.
Click here for file
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Additional file 3: Pairwise analysis of differentially expressed genes
in KK1 cells. Group RA: Mad vs. VP16.
Click here for file
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S3.XLS]
Additional file 4: Comprehensive listing of potential Foxl2 target
genes of known function generated by microarray analysis. Group
designations: (-) decreased fold expression; (+) increased fold expression.
NA = Normal: Activated (mock transfected compared to Foxl2-VP16
transfected). NR = Normal: Repressed (mock transfected compared Foxl2-
Mad transfected). RA = Repressed: Activated (Foxl2-Mad compared to
Foxl2-VP16). E16 = mouse embryonic stage day 16. E13 = mouse
embryonic stage day 13. P0 = mouse birth stage.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
S4.XLS]
Additional file 5: Combined analysis of differentially expressed
genes in KK1 cells. Normal: mock transfected. Activated: Foxl2-VP16
transfected. Repressed: Fodl2-Mad transfected.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
S5.XLS]
Additional file 6: Analysis of differentially expressed genes in E13.
Wild type vs. Foxl2 knockout.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
S6.XLS]
Additional file 7: Analysis of differentially expressed genes in E16.
Wild type vs. Foxl2 knockout.
Click here for file
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S7.XLS]
Additional file 8: Analysis of differentially expressed genes in P0.
Wild type vs. Foxl2 knockout.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
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Additional file 9: Comparison of differentially expressed genes in
KK1 cells to E13, E16, and P0. Sheet 1 lists 225 genes common to KK1
and E13. Sheet 2 lists 211 genes common to KK1 and E16. Sheet 3 lists
325 genes common to KK1 and P0. Sheet 4 lists 5 genes common to all
3 groups. Sheet 5 lists 22 common genes. Sheet 6 lists 29 common
genes. Sheet 7 lists 21 common genes. Sheet 8 lists 155 genes unique to
KK1 & E16. Sheet 9 lists 177 genes unique to KK1 & E13. Sheet 10 lists
270 genes unique to KK1 & P0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1757-2215-3-4-
S9.XLS]
Additional file 10: Potential Foxl2 target genes validated by
comparison to data from other microarray studies. Gene Functions
were obtained from the Ovarian kaleidoscope data base
1, NCBI RefSeq
2,
and UniProtKB/Swiss-Prot
3. All genes listed that do not have an asterisk
after the gene symbol are common to our study and the in vivo in
mouse ovary study only [7]. Genes denoted by a single asterisk* are
common to our study and the human KGN cell line only [6]. Those
indicated by ** are common to all three studies. The StAR*** and
GnRHR*** genes were found to be Foxl2 regulated in our study and do
not appear in the KGN [6] or in vivo [7] studies. Fold change numbers
indicate relative gene expression levels. Group designations: (-) decreased
fold expression; (+) increased fold expression. NA = Normal: Activated
(mock transfected compared to Foxl2-VP16 transfected). NR = Normal:
Repressed (mock transfected compared Foxl2-Mad transfected). RA =
Repressed: Activated (Foxl2-Mad compared to Foxl2-VP16). E16 = mouse
embryonic stage day 16. E13 = mouse embryonic stage day 13. P0 =
mouse birth stage.
Click here for file
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